CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q1 2016. The put-call ratio across all filers is 9.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $226,000 | -47.8% | 17,896 | -45.6% | 0.00% | -50.0% |
| Q2 2018 | $433,000 | -36.6% | 32,896 | -34.5% | 0.00% | -42.9% |
| Q1 2018 | $683,000 | +118.9% | 50,246 | -4.1% | 0.01% | +133.3% |
| Q4 2017 | $312,000 | -20.8% | 52,396 | -1.2% | 0.00% | -25.0% |
| Q3 2017 | $394,000 | -19.6% | 53,046 | +1.2% | 0.00% | -33.3% |
| Q2 2017 | $490,000 | -13.0% | 52,396 | -32.3% | 0.01% | -14.3% |
| Q1 2017 | $563,000 | -1.7% | 77,396 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $573,000 | -25.5% | 77,396 | -39.2% | 0.01% | -36.4% |
| Q3 2016 | $769,000 | +192.4% | 127,396 | +117.8% | 0.01% | +175.0% |
| Q2 2016 | $263,000 | +110.4% | 58,496 | +17.0% | 0.00% | +100.0% |
| Q1 2016 | $125,000 | -69.1% | 50,000 | 0.0% | 0.00% | -75.0% |
| Q4 2015 | $405,000 | +33.7% | 50,000 | 0.0% | 0.01% | +33.3% |
| Q3 2015 | $303,000 | -26.5% | 50,000 | 0.0% | 0.01% | -25.0% |
| Q2 2015 | $412,000 | +9.0% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $378,000 | -53.9% | 50,000 | -58.3% | 0.01% | -57.9% |
| Q4 2014 | $820,000 | +51.9% | 120,000 | 0.0% | 0.02% | +35.7% |
| Q3 2014 | $540,000 | -23.1% | 120,000 | 0.0% | 0.01% | -22.2% |
| Q2 2014 | $702,000 | -11.8% | 120,000 | 0.0% | 0.02% | -21.7% |
| Q1 2014 | $796,000 | – | 120,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |